Bulletin
Investor Alert

New York Markets Open in:

Revolution Medicines Inc.

NAS: RVMD

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Mar 21, 2023, 5:23 p.m.

/zigman2/quotes/216320743/composite

$

21.00

Change

-0.37 -1.73%

Volume

Volume 16,414

Quotes are delayed by 20 min

/zigman2/quotes/216320743/composite

Previous close

$ 21.77

$ 21.37

Change

-0.40 -1.84%

Day low

Day high

$21.32

$22.41

Open

52 week low

52 week high

$14.08

$31.37

Open

Insider Actions for Revolution Medicines Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
02/22/2023 Mark A. Goldsmith
See Remarks; Director
45,000   Derivative/Non-derivative trans. at $0.49 per share. 22,050
12/19/2022 Stephen M. Kelsey
See Remarks
1,220   Disposition at $22.94 per share. 27,986
12/19/2022 Margaret A. Horn
See Remarks
1,220   Disposition at $22.94 per share. 27,986
12/19/2022 Xiaolin Wang
See Remarks
708   Disposition at $22.94 per share. 16,241
12/19/2022 Jack Anders
Chief Financial Officer
658   Disposition at $22.94 per share. 15,094
11/07/2022 Margaret A. Horn
See Remarks
17,767   Disposition at $20.15 per share. 358,005
10/31/2022 Margaret A. Horn
See Remarks
17,767   Disposition at $20.41 per share. 362,624
10/26/2022 Margaret A. Horn
See Remarks
17,768   Disposition at $20.15 per share. 358,025
09/19/2022 Stephen M. Kelsey
See Remarks
1,267   Disposition at $19.04 per share. 24,123
09/19/2022 Margaret A. Horn
See Remarks
1,267   Disposition at $19.04 per share. 24,123
09/19/2022 Xiaolin Wang
See Remarks
735   Disposition at $19.04 per share. 13,994
09/19/2022 Jack Anders
Chief Financial Officer
449   Disposition at $19.04 per share. 8,548
09/01/2022 Jack Anders
Chief Financial Officer
10,000   Award at $0 per share. 0
08/11/2022 Mark A. Goldsmith
See Remarks; Director
10,000   Derivative/Non-derivative trans. at $0.49 per share. 4,900
08/09/2022 Mark A. Goldsmith
See Remarks; Director
10,336   Derivative/Non-derivative trans. at $0.49 per share. 5,064
07/22/2022 Nextech Invest AG
Director
250,000   Acquisition at $20 per share. 5,000,000
07/22/2022 Lorence H. Kim
Director
50,000   Acquisition at $20 per share. 1,000,000

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
0 Sales
45,000
0
Last 6 months
1 Purchases
7 Sales
45,000
57,108
Last 12 months
19 Purchases
17 Sales
567,298
484,088

Officers and Executives

Dr. Mark A. Goldsmith
Chairman, President & Chief Executive Officer
Dr. Margaret A. Horn
Chief Operating Officer
Mr. Jack Anders
Chief Financial Officer
Dr. Stephen M. Kelsey
President-Research & Development
Dr. Walter Reiher
Chief Information Officer
Dr. Xiao Lin Wang
Executive Vice President-Clinical Development
Ms. Linnet Zia
VP-Strategy, Financial Planning & Analysis
Mr. Daniel Simon
Chief Business Officer
Dr. Sushil Patel
Director
Ms. Luan M. Wilfong
Chief Human Resources Officer
Mr. Jeff Cislini
Secretary, Senior Vice President & General Counsel
Dr. Eric Schmidt
Independent Director
Dr. Flavia Borellini
Independent Director
Dr. Lorence H. Kim
Independent Director
Ms. Elizabeth McKee Anderson
Independent Director
Mr. Alexis A. Borisy
Lead Independent Director
Dr. Thilo Schroeder
Independent Director
Dr. Barbara L. Weber
Independent Director
Link to MarketWatch's Slice.